Table 3.
Important characteristics of presenting research findings
All (n = 577) n (%) |
Clinical practitioner (n = 316) n (%) |
Public health practitioner (n = 261) n (%) |
P-value 1 | |
---|---|---|---|---|
Relevant to the patients or populations we serve | 0.005 | |||
Very/extremely important | 527 (91.5) | 278 (88.3) | 249 (95.4) | |
Moderately important | 45 (7.8) | 34 (10.8) | 11 (4.2) | |
Not at all/slightly important | 4 (0.7) | 3 (0.9) | 1 (0.4) | |
Presents practical advice about implementation | 0.001 | |||
Very/extremely important | 511 (88.7) | 264 (83.8) | 247 (94.6) | |
Moderately important | 59 (10.2) | 45 (14.3) | 14 (5.4) | |
Not at all/slightly important | 6 (1.0) | 6 (1.9) | 0 (0.0) | |
Tells a story of how an issue affects the patients/populations we serve | 0.000 | |||
Very/extremely important | 399 (69.3) | 196 (62.2) | 203 (77.8) | |
Moderately important | 125 (21.7) | 82 (26.0) | 43 (16.5) | |
Not at all/slightly important | 52 (9.0) | 37 (11.8) | 15 (5.8) | |
Provides data on cost-effectiveness | 0.318 | |||
Very/extremely important | 328 (56.9) | 185 (58.7) | 143 (54.8) | |
Moderately important | 195 (33.9) | 106 (33.7) | 89 (34.1) | |
Not at all/slightly important | 53 (9.2) | 24 (7.6) | 29 (11.1) | |
Delivered by someone I know and respect | 0.044 | |||
Very/extremely important | 289 (50.2) | 171 (54.3) | 118 (45.2) | |
Moderately important | 163 (28.3) | 87 (27.6) | 76 (29.1) | |
Not at all/slightly important | 124 (21.5) | 57 (18.1) | 67 (25.7) | |
Provides data on access/insurance coverage | 0.239 | |||
Very/extremely important | 282 (49.0) | 159 (50.5) | 123 (47.1) | |
Moderately important | 196 (34.0) | 98 (31.3) | 98 (37.6) | |
Not at all/slightly important | 98 (17.0) | 58 (18.4) | 40 (15.3) |
Bolded p-value significant at p < 0.05, based on tests of differences between clinical and public health practitioners.